Exogene

Oxford, GB · 1 known investors

Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors. It develops cell therapies aimed at cancer treatment by mining the TCR sequence space to identify safe, non-cross-reactive receptors against shared tumor targets.

AI & Machine LearningBiotechDeep Tech